{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:48:32Z","timestamp":1791082112400,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T00:00:00Z","timestamp":1476057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0164191","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T17:39:41Z","timestamp":1476121181000},"page":"e0164191","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice"],"prefix":"10.1371","volume":"11","author":[{"given":"Tsuyoshi","family":"Chiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachina","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Umegaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,10,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"QM Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"ref2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1440-1746.2010.06548.x","article-title":"Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground","volume":"26","author":"S Chitturi","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study","volume":"47","author":"Y Eguchi","year":"2012","journal-title":"Journal of gastroenterology"},{"issue":"Suppl 4","key":"ref4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.12271","article-title":"Characteristics and diagnosis of NAFLD\/NASH","volume":"28","author":"E Hashimoto","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"ref5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jgh.12212","article-title":"Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches","volume":"28","author":"D Schuppan","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"J Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-126-2-199701150-00008","article-title":"Nonalcoholic steatohepatitis","volume":"126","author":"SG Sheth","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"G Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.14.185","article-title":"Non-alcoholic fatty liver disease and the metabolic syndrome: an update","volume":"14","author":"RS Rector","year":"2008","journal-title":"World J Gastroenterol"},{"key":"ref10","article-title":"Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame","author":"SH Ibrahim","year":"2015","journal-title":"Digestive diseases and sciences"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"574832","DOI":"10.1155\/2015\/574832","article-title":"Nonalcoholic Steatohepatitis: A Search for Factual Animal Models","volume":"2015","author":"SC Sanches","year":"2015","journal-title":"BioMed research international"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1046\/j.1440-1746.2003.03198.x","article-title":"Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies","volume":"18","author":"R Kirsch","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","author":"ME Rinella","year":"2004","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e0127991","DOI":"10.1371\/journal.pone.0127991","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","author":"MV Machado","year":"2015","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"G891","DOI":"10.1152\/ajpgi.00193.2013","article-title":"IFN-gamma deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet","volume":"305","author":"XY Luo","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.dld.2011.11.010","article-title":"Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis","volume":"44","author":"F Salamone","year":"2012","journal-title":"Dig Liver Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1292\/jvms.67.235","article-title":"Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats","volume":"67","author":"WI Jeong","year":"2005","journal-title":"J Vet Med Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.21874","article-title":"Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet","volume":"46","author":"N Matsuzawa","year":"2007","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"G483","DOI":"10.1152\/ajpgi.00079.2013","article-title":"Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment","volume":"305","author":"JR Clapper","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3945\/jn.109.117937","article-title":"Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content","volume":"140","author":"RM Machado","year":"2010","journal-title":"J Nutr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"J Folch","year":"1957","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"DE Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1194\/jlr.R700019-JLR200","article-title":"Phosphatidylcholine and choline homeostasis","volume":"49","author":"Z Li","year":"2008","journal-title":"J Lipid Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1096\/fj.01-0401rev","article-title":"S-Adenosylmethionine: a control switch that regulates liver function","volume":"16","author":"JM Mato","year":"2002","journal-title":"FASEB J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1568016054368197","article-title":"Influence of impaired liver methionine metabolism on the development of vascular disease and inflammation","volume":"3","author":"MA Avila","year":"2005","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1474-9726.2005.00152.x","article-title":"Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance","volume":"4","author":"RA Miller","year":"2005","journal-title":"Aging Cell"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1474-9726.2006.00220.x","article-title":"Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction","volume":"5","author":"VL Malloy","year":"2006","journal-title":"Aging Cell"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M109.099333","article-title":"Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione","volume":"285","author":"F Caballero","year":"2010","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1","volume":"274","author":"P Delerive","year":"1999","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1440-1746.2011.06939.x","article-title":"Peroxisome proliferator-activated receptor-alpha agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis","volume":"27","author":"CZ Larter","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/hep.26461","article-title":"Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"58","author":"B Staels","year":"2013","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPARalpha gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis","volume":"63","author":"S Francque","year":"2015","journal-title":"J Hepatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"M Pawlak","year":"2015","journal-title":"J Hepatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14656566.2014.876992","article-title":"New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease","volume":"15","author":"A Sahebkar","year":"2014","journal-title":"Expert opinion on pharmacotherapy"},{"key":"ref35","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","author":"H Itagaki","year":"2013","journal-title":"International journal of clinical and experimental pathology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","article-title":"Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition","volume":"301","author":"M Charlton","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0164191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T04:50:21Z","timestamp":1749617421000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0164191"}},"subtitle":[],"editor":[{"given":"Giovanni","family":"Li Volti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,10]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0164191","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,10]]}}}